Schrodinger Stock Price

-2.85 (-3.07%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Big Cap Pro
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Schrodinger Inc SDGR NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-2.85 -3.07% 90.00 20:00:00
Open Price Low Price High Price Close Price Prev Close
92.20 87.61 94.4999 90.89 92.85
Bid Price Ask Price Spread News
89.00 90.90 1.90 1 -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
10,199 793,134 $ 90.48 $ 71,760,722 909,585 26.06 - 99.50
Last Trade Time Type Quantity Stock Price Currency
19:59:35 20 $ 89.43 USD

Schrodinger Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 6.25B 69.49M 30.10M $ 85.54M $ -17.15M -0.41 -229.80
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% -10.72M 1.30%

more financials information »

Schrodinger News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical SDGR Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week85.3094.499983.8989.12658,8944.705.51%
1 Month79.1994.499975.7084.02726,26210.8113.65%
3 Months58.599394.499947.5967.80996,24631.4053.59%
6 Months84.0194.499946.2764.561,224,4205.997.13%
1 Year30.4599.5026.0658.921,213,74359.55195.57%
3 Years30.4599.5026.0658.921,213,74359.55195.57%
5 Years30.4599.5026.0658.921,213,74359.55195.57%

Schrodinger Description

Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. Schrodinger generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.